-
2024-514350-78-00
5
2021-07-29
Infertility
-
2023-508372-10-00
4
2021-05-19
Non small Cell Lung cancer
-
2023-507188-21-00
5
2021-04-20
Muscle-Invasive Urothelial Carcinoma (MIBC) of the Bladder
-
2023-507970-42-00
5
2021-03-31
PSMA-positive metastatic hormone-sensitive prostate cancer (mHSPC)
-
2024-515944-22-00
4
2021-01-19
BRAFV600E-mutant metastatic Non-small Cell Lung Cancer
-
2023-503380-42-00
6
2020-11-16
patient with moderate to severe Crohn's disease
with at least one acti
-
2024-514104-14-00
4
2020-11-04
Adults subjects with advanced malignant pleural (cohort A) or peritone
-
2024-511185-37-00
6
2020-11-03
Completely resected stage I or IIA non-squamous non-small cell lung
ca
-
2024-516102-36-00
4
2020-07-29
Minimal Change Nephrotic Syndrom
-
2023-503628-22-00
5
2020-07-16
Lupus Nephritis (LN)
-
2024-518318-25-00
5
2020-06-24
Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with C
-
2023-503500-87-00
11
2020-03-17
Muscle Invasive Bladder Cancer
-
2023-508292-37-00
5
2020-03-06
Cardiovascular Disease
-
2024-512269-14-00
5
2020-01-27
GIant cell Arteritis
-
2023-510248-19-00
5
2020-01-21
Eosinophilic Granulomatosis with Polyangiitis (EGPA)
-
2024-514885-38-00
5
2019-07-11
severe forms of mucous membrane pemphigoid
-
2023-504932-16-00
5
2019-06-04
Muscle Invasive Bladder Cancer
-
2023-509169-19-00
5
2017-07-11
Advanced ALK positive non-small cell lung cancer
-
2023-509136-25-00
5
2015-07-16
Stage III melanoma (AJCC R0) with histologically confirmed cutaneous m
-
2023-507220-23-00
5
2024-07-26
Transthyretin Amyloidosis with Cardiomyopathy
-
2022-502871-49-00
3
2024-04-05
healthy volunteers
-
2023-509371-16-00
4
2024-09-25
Idiopathic Pulmonary Fibrosis
-
2023-510249-79-00
4
2024-09-10
Progressive pulmonary fibrosis (PPF)
-
2023-504920-25-00
5
2024-08-23
Hypercholesterolemia